Cytokinetics Ownership | Who Owns Cytokinetics?

Overview Forecast RevenueFinancials Chart Transcripts

Cytokinetics Ownership Summary

Cytokinetics is owned by 132.84% institutional investors, 0.50% insiders. Blackrock is the largest institutional shareholder, holding 14.40% of CYTK shares. Vanguard Health Care Inv is the top mutual fund, with 3.46% of its assets in Cytokinetics shares.

CYTK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cytokinetics	132.84%	0.50%	-33.34%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	14.67M	14.40%	$794.97M
Fmr	11.52M	11.31%	$624.32M
Vanguard group	11.44M	11.22%	$619.69M
T. rowe price investment management	8.14M	7.99%	$440.95M
Wellington management group llp	7.51M	7.37%	$406.87M
State street	6.55M	6.42%	$354.80M
Geode capital management	2.74M	2.69%	$148.41M
Rtw investments, lp	2.72M	2.67%	$147.43M
Polar capital	2.45M	2.41%	$132.99M
Price t rowe associates inc /md/	2.36M	2.31%	$127.78M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rp management	980.39K	29.71%	$53.12M
Superstring capital management lp	187.63K	12.81%	$10.17M
Sarissa capital management lp	1.11M	10.15%	$60.14M
Vestal point capital, lp	2.08M	8.38%	$112.42M
Checkpoint capital	190.00K	6.21%	$10.29M
Boxer capital	2.10M	5.99%	$113.78M
Saturn v capital management	272.04K	5.57%	$14.74M
Dafna capital management	398.10K	5.15%	$21.57M
Integral health asset management	1.00M	5.15%	$54.18M
Great point partners	474.20K	4.92%	$25.69M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	7.51M	0.07%	3.53M
T. rowe price investment management	8.14M	0.28%	3.02M
Blackrock	14.67M	0.02%	2.26M
State street	6.55M	0.02%	2.03M
Vanguard group	11.44M	0.01%	1.44M

Top Sellers

Holder	Shares	% Assets	Change
Darwin global management	-	-	-4.58M
Marshall wace, llp	1.68M	0.12%	-878.64K
Invesco	495.40K	0.01%	-822.14K
Melqart asset management (uk)	-	-	-800.10K
Avidity partners management lp	-	-	-600.00K

New Positions

Holder	Shares	% Assets	Change	Value
Rp management	980.39K	29.71%	980.39K	$53.12M
Norges bank	799.66K	0.01%	799.66K	$43.33M
Massachusetts financial services co /ma/	276.07K	0.00%	276.07K	$14.96M
Corebridge financial	204.25K	0.06%	204.25K	$11.07M
Opaleye management	198.50K	2.46%	198.50K	$10.75M

Sold Out

Holder	Change
Financial gravity asset management	-2.00
Institutional & family asset management	-7.00
Valley national advisers	-25.00
Meeder asset management	-43.00
Exchange traded concepts	-55.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	388	-14.35%	135,400,422	16.07%	132	1.01%	200	-11.11%	102	-22.14%
Mar 31, 2024	453	6.34%	116,652,886	2.18%	114	0.82%	225	10.29%	131	11.02%
Dec 31, 2023	426	52.14%	114,167,448	3.81%	118	0.90%	204	64.52%	118	47.50%
Sep 30, 2023	280	4.87%	109,978,556	0.89%	114	0.88%	124	-3.88%	80	-
Jun 30, 2023	267	-1.11%	109,010,074	0.12%	113	0.87%	129	8.40%	80	-19.19%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	4.07M	3.46%	-
Vanguard Total Stock Mkt Idx Inv	3.73M	3.17%	-16.29K
iShares Core S&P Mid-Cap ETF	3.70M	3.14%	2.00K
Vanguard Small Cap Index	2.95M	2.50%	5.76K
iShares Russell 2000 ETF	2.94M	2.49%	-6.61K
SPDR® S&P Biotech ETF	2.36M	2.01%	26.14K
T. Rowe Price US Mid-Cap Growth Equity	1.99M	1.70%	188.63K
T. Rowe Price Mid-Cap Growth	1.99M	1.70%	-4.20K
Vanguard Institutional Extnd Mkt Idx Tr	1.77M	1.50%	7.64K
Vanguard Small Cap Growth Index Inv	1.62M	1.38%	-1.98K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 18, 2024	Blum Robert I	President & CEO	Sell	$252.75K
Nov 12, 2024	Malik Fady Ibraham	EVP Research & Development	Sell	$309.94K
Nov 12, 2024	Malik Fady Ibraham	EVP Research & Development	Sell	$60.94K
Nov 01, 2024	Blum Robert I	President & CEO	Sell	$258.15K
Oct 28, 2024	WIERENGA WENDALL	-	Sell	$232.62K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	12
2024 Q3	-	25
2024 Q2	-	17
2024 Q1	-	12
2023 Q4	-	10

CYTK Ownership FAQ

Who Owns Cytokinetics?

Cytokinetics shareholders are primarily institutional investors at 132.84%, followed by 0.50% insiders and -33.34% retail investors. The average institutional ownership in Cytokinetics's industry, Biotech Stocks , is 44.97%, which Cytokinetics exceeds.

Who owns the most shares of Cytokinetics?

Cytokinetics’s largest shareholders are Blackrock (14.67M shares, 14.40%), Fmr (11.52M shares, 11.31%), and Vanguard group (11.44M shares, 11.22%). Together, they hold 36.92% of Cytokinetics’s total shares outstanding.

Does Blackrock own Cytokinetics?

Yes, BlackRock owns 14.40% of Cytokinetics, totaling 14.67M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 794.97M$. In the last quarter, BlackRock increased its holdings by 2.26M shares, a 18.19% change.

Who is Cytokinetics’s biggest shareholder by percentage of total assets invested?

Rp management is Cytokinetics’s biggest shareholder by percentage of total assets invested, with 29.71% of its assets in 980.39K Cytokinetics shares, valued at 53.12M$.

Who is the top mutual fund holder of Cytokinetics shares?

Vanguard Health Care Inv is the top mutual fund holder of Cytokinetics shares, with 3.46% of its total shares outstanding invested in 4.07M Cytokinetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools